Bromine-76 and carbon-11 labelled NNC 13-8199, metabolically stable benzodiazepine receptor agonists as radioligands for positron emission tomography (PET)

European Journal of Nuclear Medicine

Volumn 24, Issue 10, 1997, Pages 1261-1267

  Foged, Christian ^a,b   Halldin, Christer ^a   Loc'h, Christian ^c   Mazière, Bernard ^c   Pauli, Stefan ^a   Maziére, Mariannick ^c   Hansen, Holger C ^b   Suhara, Tetsuya ^a   Swahn, Carl Gunnar ^a   Karlsson, Per ^a   Farde, Lars ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b NOVO NORDISK A S   (Denmark)

^c DIF   (France)

Author keywords

Benzodiazepine receptor agonist; Bromine 76; Carbon 11; NNC 13 8199; Positron emission tomography

Indexed keywords

BENZODIAZEPINE RECEPTOR STIMULATING AGENT; BROMINE; CARBON 11; FLUMAZENIL; METHYL IODIDE; NNC 13 8199; RADIOLIGAND; TOSYLCHLORAMIDE SODIUM; TRIMETHYLTIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DRUG BLOOD LEVEL; DRUG METABOLISM; DRUG STABILITY; DRUG UPTAKE; FRONTAL CORTEX; INTRAVENOUS DRUG ADMINISTRATION; MONKEY; NONHUMAN; OCCIPITAL CORTEX; POSITRON EMISSION TOMOGRAPHY; RADIOACTIVITY; TEMPORAL CORTEX;

ANIMALS; BENZODIAZEPINES; BRAIN; BROMINE RADIOISOTOPES; CARBON RADIOISOTOPES; FLUMAZENIL; HUMANS; MACACA FASCICULARIS; MALE; OXADIAZOLES; PAPIO; RECEPTORS, GABA-A; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 9844239913     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050150     Document Type: Article

References (28)

1. 11C] RO15.1788): a specific radioligand for the in vivo study of central BZ receptor by positron emission tomography. Appl Radiat Isot 1984; 35: 973-976.
2. Hantraye P, Kaijima M, Prenant C, Giubert B, Sastre J, Crouzel M, Naquet R, Comar D, Mazière M. Central type benzodiazepine binding sites: a positron emission tomography study in the baboon's brain Neurosci Lett 1984; 48: 115-120.
3. 11C-labelled RO 15 1788 binding to benzodiazepine receptors in the human brain by positron emission tomography. J Psychiatr Res 1985; 19: 609-622.
4. 11C-RO 15-1788, a benzodiazepine antagonist studied in human brain in vivo by positron emission tomography. Eur J Pharmacol 1985; 10: 247-251.
5. 11C-RO 15 1788 to central type benzodiazepine receptors in human brain: quantitative evaluation by PET. J Cereb Blood Flow Metab 1988; 8: 304.
6. 11C]Ro 15-1788 binding to the human neocortex using positron emission tomography Hum Psychopharmacol 1989; 4: 21-31.
7. Beer HF, Blauenstein PA, Hasler PH, Delaloye B, Riccabona G, Banger I, Hunkeler W, Bonetti EP, Pieri L, Richards JG, Schubiger PA. In vitro and in vivo evaluation of iodine-123-Ro 16-0154: a new imaging agent for SPECT investigations of benzodiazepine receptors. J Nucl Med 1990; 31: 1007.
8. 123I]Ro 16-0154. Eur J Pharmacol 1991; 193: 249-252.
9. 76Br] labelled iomazenil: a direct PET-SPECT comparison. Eur J Nucl Med 1996; 23: 5-12.
10. Lassen NA. Neuroreceptor quantification in vivo by the steady-state principle using constant infusion or bolus injection of radioactive tracers. J Cereb Blood Flow Metab 1992; 12: 709-715.
11. 123I]iomazenil. Eur J Pharmacol 1993; 249: 43-51.
12. 11C-labelling of its main metabolite Ro 15-3890 for PET studies of BZ receptors. Appl Radiat Isot 1988; 39: 993-997.
13. Swahn C-G, Persson A, Pauli S. Metabolism of the BZ antagonist carbon-11 Ro 15-1788 after intravenous administration in man. Hum Psychopharmacol 1989; 4: 297-301.
14. 11C]Ro 15-3890; PET study in healthy volunteers. Hum Psychopharmacol 1989; 4: 215-220.
15. Dauth J, Höll K, Deisenhammer E. Time curves of radioactivity in plasma after injection of iomazenil Ro 16-0154. In: Proceedings of the 6th Böttstein colloquim on the use of iomazenil and other brain receptor tracers for SPECT, Basel. Roche; 1989; 33-40.
16. 123I-labelled NNC 13-8241 as a radioligand for SPECT visualization of benzodiazepine receptor binding. Nucl Med Biol 1996; 22: 201-209.
17. Kuikka JT, Hiltunen J, Foged C, Bergström KA, Halldin C, Akerman K, Farde L. Initial human studies with single-photon emission tomography using iodine-123 labelled 3-(5-cyclopropyl-1,2,4-oxadiazo-3-yl)-7-iodo-5,6-dihydro-5-methyl-6-oxo-4H- imidazo[1,5a][1,4]-benzodiazepine. Eur J Nucl Med 1996; 23: 798-803.
18. 76Br]NNC 13-8199, partial agonists for the study of benzodiazepine receptors using PET. J Label Comp Radiopharm 1994; 35: 450-451.
19. Wong G, Uosi-Oukari M, Hansen HC, Suzdak PD, Korpi ER. Characterization of noval ligands for wild-type and natural mutant diazepam-insensitive benzodiazepine receptors. Eur J Pharmacol 1995; 289: 335-342.
20. Halldin C, Swahn C-G, Farde L, Sedvall G. Radioligand disposition and metabolism - key information in early drug development. In: Comar D (ed) PET for drug development. Developments in nuclear medicine. The Hague: Kluwer Academic; 1995: 26.
21. 11C]raclopride. J Label Comp Radiopharm 1993; 32: 284-285.
22. 11C]SCH23390. Identification of two metabolites with HPLC. Hum Psychopharmacol 1994; 9: 25-31.
23. Watjen F, Baker R, Engelstoff M, Herbert R, MacLeod A, Knight A, Merchant K, Moseley J, Saunders J, Swain CJ, Wong W, Springer JP. Novel benzodiazepine receptor partial agonists: oxadiazolylimidazobenzodiazepines. J Med Chem 1989; 32: 2282-2291.
24. 76Br-MBBG, a PET radiotracer to investigate the norepinephrine neurological and vesicular transporters in the heart. J Nucl Med Biol 1995; 22: 1049-1052.
25. Loc'h C, Hantraye P, Khalili-Varasteh M, Maziére B, Delforge J, Brouillet B, Syrota A, Maziére B. C-11 Flumazenil metabolism: analysis of unchanged ligand in baboon plasma. J Nucl Med 1990; 31: 897.
26. 11C-Labelling of eticlopride in two different positions - a selective high-affinity ligand for the study of dopamine D-2 receptors using PET. Appl Radiat Isot 1990; 41: 669-674.
27. Weinhard K, Dahlbom M, Eriksson L, Michel C, Bruckbaruer T, Pietrzyk U, Heiss W-D. The ECAT EXACT HR: performance of a new high resolution positron scanner. J Comput Assist Tomogr 1994; 18: 110-118.
28. 11C-NNC756 as new radioligands for the D1 dopamine receptor. Psychopharmacology 1993; 113: 149-156.